Advancing New Standards in Reproductive Health (ANSIRH)
Oakland, California, 94612, United States
Location status: Recruiting
Location contact
Jennifer Ko, MLIS
CONTACT
Ushma Upadhyay, PhD, MPH
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06787274
This study will examine the ways in which telehealth for reproductive healthcare affects timing, costs, and follow-up care; whether telehealth reaches people in areas with greater health inequities; and the attributes of telehealth that patients want. Study surveys will be administered to interested, eligible participants: 2,000 patients seeking abortion care will complete the study, comprising of 2 groups: patients seeking medication abortion care either (1) in-person or (2) via telehealth. This project will address how telehealth services can be optimized for people of color, low-income people, and immigrants to increase digital inclusion and health equity.
Interested in participating?
Request Info14 year–64 year
All sexes
Observational
Oakland, California, 94612, United States
Location status: Recruiting
Jennifer Ko, MLIS
CONTACT
Ushma Upadhyay, PhD, MPH
PRINCIPAL_INVESTIGATOR
Given the novelty of telehealth abortion services and new abortion bans, there is a critical need for research on the role of telehealth for abortion to expand equitable abortion access among groups historically marginalized in healthcare. Outside of abortion care, telehealth appears to 1) bridge geographic disparities,2) facilitate language translation,3) provide privacy and safety for immigrants with varying legal statuses, 4) decrease patient costs, and 5) require less time off work or school. At the same time, telehealth services could exacerbate inequities if patients lack technology, internet connectivity, or digital literacy. Because abortion is overregulated and highly stigmatized, research on telehealth for abortion is vital. The investigators hypothesize that telehealth is associated with several benefits compared to in-person abortion care, but is not yet reaching people in areas with greater health inequities who need these innovations most. This research can also inform the policies in states that are considering ways to support people in banned states.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Descriptive statistics for the elapsed days from the first pregnancy test to 1) date of the decision to have an abortion, 2) date of first contact with the clinic, 3) date of medication receipt, and 4) date mifepristone (the first medication) was ingested.
Time frame: Baseline and 1 week
Report of 1) out-of-pocket costs for the abortion and 2) the costs of related expenses, including transportation, childcare, lost work, and other expenses.
Time frame: 1 week
The incidence of unplanned in-person follow-up visits to a clinician, emergency room, or other facility, between participants in the telehealth and in-person groups using logistic regression models.
Time frame: Baseline and 1 week
We will conduct a discrete choice analysis to understand participant preferred choices for hypothetical delivery alternatives to telehealth abortion.
Time frame: Baseline and 1 week
The barriers to hypothetical delivery alternatives to telehealth abortion between participants in the telehealth and in-person groups using a discrete choice model
Contact information is provided by the study sponsor or research team.
Jennifer Ko, MLIS
CONTACT
Ushma Upadhyay, PhD, MPH
CONTACT
University of California, San Francisco
Other
Improving Health Equity by Understanding Preferences in Telehealth Abortion
Acronym: REACH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05182008
Abortion Early, Abortion in First Trimester
Halifax, Nova Scotia, Canada
View Trial DetailsNCT03636451
Abortion Early, Abortion in First Trimester
La Jolla, California, United States
View Trial DetailsNCT03417362
Abortion Early, Abortion in First Trimester
Paris, France
View Trial DetailsNCT05341817
Abortion in First Trimester
Singapore
View Trial Details